Form 4 Option Care Health, Inc. For: May 20 Filed by: KRAEMER HARRY M JANSEN JR

May 24, 2022 6:07 PM EDT

News and research before you hear about it on CNBC and others. Claim your 1-week free trial to StreetInsider Premium here.
Washington, D.C. 20549


Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB Number: 3235-0287
Expires: December 31, 2014
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person *

(Last) (First) (Middle)


(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
Option Care Health, Inc. [ OPCH ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.0001 05/20/2022   A   9,555 A $ 0 (1) 159,965 D  
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Explanation of Responses:
1. The reporting person received an award of restricted stock units on May 20, 2022. The number of restricted stock units granted was calculated to reflect $276,000 of value based on the closing price of the issuer's common stock on May 19, 2022.
Exhibit 24.1 Power of Attorney
/s/ Sarah Kim, attorney-in-fact for Mr. Kraemer 05/24/2022
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
Exhibit 24.1
APRIL 1, 2022


KNOW ALL BY THESE PRESENTS, that the undersigned
hereby constitutes and appoints each of Michael
Shapiro, Sarah Kim and Michael Bavaro, signing
singly, the undersigned?s true and lawful
attorney-in-fact to: (i) execute for and on
behalf of the undersigned, in the undersigned?s
capacity as an officer and/or director and/or
owner of greater than 10% of the outstanding
shares of common stock of Option Care Health,
Inc., a Delaware corporation (the ?Company?),
Forms 3, 4 and 5 (including any amendments,
supplements or exhibits thereto) in
accordance with Section 16(a) of the
Securities Exchange Act of 1934 and the
rules thereunder; (ii) do and perform any
and all acts for and on behalf of the
undersigned which may be necessary or
desirable to complete and execute any such
Form 3, 4 or 5 (including any amendments,
supplements or exhibits thereto) and
timely file such form with the United
States Securities and Exchange Commission
(the ?SEC?) and any stock exchange or
similar authority, including the New
York Stock Exchange, and including
without limitation the filing of a
Form ID or any other documents necessary
or appropriate to enable the undersigned
to file the Form 3, 4 and 5
electronically with the SEC;
(iii) seek or obtain, as the undersigned?s
representative and on the undersigned?s
behalf, information on transactions
in the Company?s securities from any
third party, including brokers, employee
benefit plan administrators and trustees,
and the undersigned hereby authorizes
any such person to release any such
information to each of the undersigned?s
attorneys-in-fact appointed by this Power
of Attorney and ratifies any such release
of information; and (iv) take any other
action of any type whatsoever in
connection with the foregoing which, in
the opinion of such attorney-in-fact,
may be of benefit to, in the best interest
of, or legally required by, the undersigned,
it being understood that the documents
executed by such attorney-in-fact on
behalf of the undersigned pursuant to
this Power of Attorney shall be in such form
and shall contain such terms and conditions
as such attorney-in-fact may approve in
such attorney-in-fact?s discretion.

The undersigned hereby grants to each such
attorney-in-fact full power and authority
to do and perform any and every act and
thing whatsoever requisite, necessary or
proper to be done in the exercise of any
of the rights and powers herein granted,
as fully to all intents and purposes as
the undersigned might or could do if
personally present, with full power of
substitution or revocation, hereby ratifying
and confirming all that such attorney-in-fact,
or such attorney-in-fact?s substitute or
substitutes, shall lawfully do or cause to
be done by virtue of this power of attorney
and the rights and powers herein granted.
The undersigned acknowledges that the
foregoing attorneys-in-fact, in serving
in such capacity at the request of the
undersigned, are not assuming, nor is the
Company assuming, any of the undersigned?s
responsibilities to comply with Section 16
of the Securities Exchange Act of 1934.

This Power of Attorney shall remain in
full force and effect until the undersigned
is no longer required to file Forms 3, 4
and 5 with respect to the undersigned?s
holdings of and transactions in securities
issued by the Company, unless earlier
revoked by the undersigned in a signed
writing delivered to the
foregoing attorneys-in-fact.

IN WITNESS WHEREOF, the undersigned has
caused this Power of Attorney to be
executed as of date first written above.

Signed and acknowledged:

/s/ Harry M. Jansen Kraemer, Jc.
Harry M. Jansen Kraemer, Jc.

Serious News for Serious Traders! Try Premium Free!

You May Also Be Interested In

Related Categories

SEC Filings